Amphastar Pharmaceuticals, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $135.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $24.0M | 17.8% |
| Other Investing | $8.7M | 6.5% |
| Stock Repurchases | $39.9M | 29.5% |
| Working Capital | $32.7M | 24.2% |
| Net Cash Flow | $29.7M | 22.0% |